Rani Therapeutics Holdings, Inc. financial data

Symbol
RANI on Nasdaq
Industry
Pharmaceutical Preparations
Location
2051 Ringwood Avenue, San Jose, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 673 % -61%
Debt-to-equity 230 % +277%
Return On Equity -108 % -164%
Return On Assets -49.9 % -58.8%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 54.1 M USD -57.8%
Weighted Average Number of Shares Outstanding, Basic 26 M shares +3.15%
Weighted Average Number of Shares Outstanding, Diluted 26 M shares +3.15%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 37.5 M USD -3.18%
General and Administrative Expense 26.1 M USD -4.88%
Operating Income (Loss) -63.6 M USD +3.88%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -67.9 M USD -7.28%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -33.1 M USD -1.05%
Earnings Per Share, Basic -1.29 USD/shares +32.1%
Earnings Per Share, Diluted -1.29 USD/shares +32.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.88 M USD -63.8%
Marketable Securities, Current 98.5 M USD
Assets, Current 41.4 M USD -53.5%
Property, Plant and Equipment, Net 5.91 M USD -1.34%
Operating Lease, Right-of-Use Asset 5.97 M USD +320%
Other Assets, Noncurrent 246 K USD
Assets 53.5 M USD -44.5%
Accounts Payable, Current 806 K USD -46.7%
Accrued Liabilities, Current 2.3 M USD +60.1%
Liabilities, Current 13.4 M USD +160%
Operating Lease, Liability, Noncurrent 4.75 M USD +850%
Liabilities 39 M USD +11.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -11 K USD -10%
Retained Earnings (Accumulated Deficit) -80.4 M USD -70%
Stockholders' Equity Attributable to Parent 7.4 M USD -75.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 14.5 M USD -76.4%
Liabilities and Equity 53.5 M USD -44.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.4 M USD +22.6%
Net Cash Provided by (Used in) Financing Activities 121 K USD +1413%
Net Cash Provided by (Used in) Investing Activities 10.3 M USD +150%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.01 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.38 M USD -62.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.18 M USD +473%
Deferred Tax Assets, Valuation Allowance 61 M USD +15.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 61 M USD +15.5%
Operating Lease, Liability 5.97 M USD +320%
Depreciation 800 K USD +60%
Payments to Acquire Property, Plant, and Equipment 18 K USD -92.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -33.1 M USD -1.03%
Lessee, Operating Lease, Liability, to be Paid 7.5 M USD +389%
Property, Plant and Equipment, Gross 5.87 M USD +31.3%
Operating Lease, Liability, Current 1.22 M USD +32.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.9 M USD +142%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.3 M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.53 M USD +1275%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.23 M USD +64.1%
Deferred Tax Assets, Operating Loss Carryforwards 13 M USD +90.7%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 70 K USD +70.7%
Preferred Stock, Shares Authorized 20 M shares 0%
Unrecognized Tax Benefits 489 K USD +132%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.28 M USD
Operating Lease, Payments 180 K USD -30.5%
Additional Paid in Capital 87.8 M USD +12.5%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 2 K USD -33.3%
Current Federal Tax Expense (Benefit) 68 K USD +78.9%
Deferred Tax Assets, Net of Valuation Allowance 18.9 M USD +1.07%
Share-based Payment Arrangement, Expense 19 M USD +20.4%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 5.17 M USD +127%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%